Clarivate and CAPES Expand Landmark Partnership to Power Research and Innovation Across Brazil

by Chief Editor

Clarivate’s Partnership with CAPES: Shaping the Future of Brazilian Research

The recent renewal of the partnership between Clarivate Plc and CAPES in Brazil marks a significant step forward for scientific research. This collaboration, delivering critical academic and life sciences insights, promises to broaden access to vital data and drive national research excellence. But what does this mean for the future, and how will it impact researchers and institutions?

Expanding Access: The Cornerstone of Innovation

The core of this agreement centers around expanding access. By increasing institutional coverage by 57%, Clarivate and CAPES are ensuring that high-quality research tools reach universities and research centers across Brazil, from bustling metropolitan areas to remote regions. This democratization of data is crucial for fostering a more equitable and innovative research landscape.

Did you know? Access to comprehensive research databases has a direct correlation with increased research output and the development of novel solutions, particularly in areas like healthcare and sustainable development.

Key Solutions: Fueling Scientific Advancement

The agreement provides access to a suite of critical tools, including Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence, and Derwent Innovation Index. These resources offer researchers a comprehensive overview of global research trends, publication impact, and innovation pathways. This empowers researchers to conduct innovative studies, develop new treatments, and influence policy decisions.

Pro Tip: Take advantage of these resources to identify research gaps, collaborate with international partners, and maximize the impact of your work. Explore the Web of Science to discover emerging trends in your research field.

Impact on Life Sciences and Healthcare

The partnership’s implications for the life sciences and healthcare sectors are particularly noteworthy. With expanded access to Cortellis Drug Discovery Intelligence, Brazilian researchers gain a competitive edge. This platform provides insights across biology, pharmacology, and chemistry, helping accelerate drug discovery and improve patient care. This support is particularly valuable for postgraduate students, faculty, and biomedical researchers. This can help improve patient outcomes and create new treatment options.

Addressing Regional Disparities and Fostering Inclusivity

One of the primary goals of this initiative is to reduce regional disparities in access to research resources. By ensuring that institutions in underserved and remote regions have the same access to high-quality data as their counterparts in major urban centers, CAPES and Clarivate are promoting inclusive academic excellence. This approach can facilitate impactful research and create equal opportunities for researchers from all areas.

The Role of Data in Shaping Policy and Benchmarking

The data provided through this partnership is not just for researchers; it’s also a powerful tool for policymakers and institutional leaders. Access to resources like the Journal Citation Reports and Derwent Innovation Index provides deeper visibility into global research trends, allowing policymakers to make more informed decisions about research funding, support, and areas of investment. This capability is invaluable for institutional benchmarking and scholarly advancement.

Brazil’s Research Landscape: A Global Perspective

Brazil is rapidly emerging as a significant player in global research. The nation boasts a strong focus on the Life Sciences, with a focus on impact in Medicine. The country’s research outputs are also heavily focused on Sustainable Development Goals (SDGs) Zero Hunger (SDG 2) and Life on Land (SDG 15), showing a commitment to addressing pressing global challenges.

Want to learn more about Brazil’s scientific strengths and the role of international collaborations? Read our article: “The Increasing Importance of International Collaboration in Scientific Research.”

Frequently Asked Questions

What is CAPES?

CAPES (Coordenação de Aperfeiçoamento de Pessoal de Nível Superior) is a key agency under Brazil’s Ministry of Education, focused on advancing postgraduate education and fostering international scientific collaboration.

What is Clarivate?

Clarivate is a leading global provider of transformative intelligence, offering data, insights, and analytics to academic and government organizations, intellectual property professionals, and the life sciences and healthcare industry.

What benefits does this partnership offer?

The partnership provides expanded access to vital research tools and data, empowers researchers to conduct innovative studies, accelerates drug discovery, and helps address regional disparities in access to resources.

What resources will Brazilian institutions have access to?

Institutions will have access to the Web of Science, Journal Citation Reports, Cortellis Drug Discovery Intelligence, and Derwent Innovation Index.

How does this collaboration impact Brazilian researchers?

This partnership empowers Brazilian researchers to conduct innovative research, develop new treatments, and improve patient care. The tools provided help to identify research gaps and maximize the impact of their work.

How can I stay informed?

To learn more, visit the official Clarivate website and explore related articles here. Also, subscribe to our newsletter for the latest updates and insights.

Ready to explore the future of research? Share your thoughts in the comments below. What are your predictions for Brazilian research in the coming years? How do you think partnerships like this will reshape scientific discovery?

You may also like

Leave a Comment